Real-world evaluation of effectiveness, persistence and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.

17/05/2021
02/07/2024
EU PAS number:
EUPAS39635
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A3921398 Final Non-Interventional Protocol Study Abstract

English (1.24 MB - PDF) View document
Updated protocol

A3921398 Non-Interventional Study Protocol 04 March 2021

First published: 22/02/2024
English (1.87 MB - PDF) View document
Study results
Study report
Study report

A3921398 Non Interventional Study Report 19 July 2022_Redacted

English (6.43 MB - PDF) View document

A3921398 Non Interventional Study Report Abstract 19 July 2022_Redacted

English (1.93 MB - PDF) View document
Other information
Study, other information

A3921398 Non Interventional Study Report Abstract 19 July 2022_Redacted.pdf

English (1.93 MB - PDF) View document